Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALMOTRIPTAN vs ALOGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALMOTRIPTAN vs ALOGLIPTIN: Safety Overview

Metric ALMOTRIPTAN ALOGLIPTIN
Total FAERS Reports 279 1,385
Deaths Reported 27 122
Death Rate 9.7% 8.8%
Hospitalizations 76 567
Average Patient Age 49.5 yrs 69.0 yrs
% Female Patients 42.4% 41.0%
FDA Approval Date N/A Jan 25, 2013
Manufacturer N/A Padagis Israel Pharmaceuticals Ltd
Route N/A ORAL
Marketing Status N/A Prescription